HIV/Aids Stocks List

Related ETFs - A few ETFs which own one or more of the above listed HIV/Aids stocks.

HIV/Aids Stocks Recent News

Date Stock Title
May 10 OSUR OraSure Technologies Inc (OSUR) Q1 2024 Earnings: Revenue Decline Amidst Strategic Restructuring
May 10 VTRS Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript
May 10 VTRS Viatris Inc. (VTRS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic Shifts and ...
May 10 OSUR OraSure Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 10 NNVC NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City
May 10 VTRS Q1 2024 Viatris Inc Earnings Call
May 9 VTRS Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast
May 9 OSUR OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2024 Earnings Call Transcript
May 9 VTRS Viatris Inc. (VTRS) Q1 2024 Earnings Call Transcript
May 9 VTRS Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
May 9 VTRS Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
May 9 VTRS Viatris Inc. 2024 Q1 - Results - Earnings Call Presentation
May 9 OSUR Q1 2024 OraSure Technologies Inc Earnings Call
May 9 VTRS Viagra maker Viatris misses revenue estimates on weak demand for older drugs
May 9 VTRS Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
May 9 VTRS Viatris in charts: Net sales drop Y/Y across all markets in Q1
May 9 LH We Think Shareholders May Want To Consider A Review Of Laboratory Corporation of America Holdings' (NYSE:LH) CEO Compensation Package
May 9 VTRS Earnings Summary: Viatris reports mixed Q1 results, reaffirms FY2024 outlook
May 9 VTRS Viatris Non-GAAP EPS of $0.67 in-line, revenue of $3.66B misses by $30M
May 9 VTRS Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
HIV/Aids

Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV). Following initial infection a person may not notice any symptoms, or may experience a brief period of influenza-like illness. Typically, this is followed by a prolonged period with no symptoms. If the infection progresses, it interferes more with the immune system, increasing the risk of developing common infections such as tuberculosis, as well as other opportunistic infections, and tumors which are otherwise rare in people who have normal immune function. These late symptoms of infection are referred to as acquired immunodeficiency syndrome (AIDS). This stage is often also associated with unintended weight loss.HIV is spread primarily by unprotected sex (including anal and oral sex), contaminated blood transfusions, hypodermic needles, and from mother to child during pregnancy, delivery, or breastfeeding. Some bodily fluids, such as saliva, sweat and tears, do not transmit the virus. HIV is a member of the group of viruses known as retroviruses.Methods of prevention include safe sex, needle exchange programs, treating those who are infected, and pre- & post-exposure prophylaxis. Disease in a baby can often be prevented by giving both the mother and child antiretroviral medication. There is no cure or vaccine; however, antiretroviral treatment can slow the course of the disease and may lead to a near-normal life expectancy. Treatment is recommended as soon as the diagnosis is made. Without treatment, the average survival time after infection is 11 years.In 2018, about 37.9 million people were living with HIV and it resulted in 770,000 deaths. An estimated 20.6 million of these live in eastern and southern Africa. Between the time that AIDS was identified (in the early 1980s) and 2018, the disease caused an estimated 32 million deaths worldwide. HIV/AIDS is considered a pandemic—a disease outbreak which is present over a large area and is actively spreading. HIV made the jump from other primates to humans in west-central Africa in the early-to-mid 20th century. AIDS was first recognized by the United States Centers for Disease Control and Prevention (CDC) in 1981 and its cause—HIV infection—was identified in the early part of the decade.
HIV/AIDS has had a large impact on society, both as an illness and as a source of discrimination. The disease also has large economic impacts. There are many misconceptions about HIV/AIDS, such as the belief that it can be transmitted by casual non-sexual contact. The disease has become subject to many controversies involving religion, including the Catholic Church's position not to support condom use as prevention. It has attracted international medical and political attention as well as large-scale funding since it was identified in the 1980s.

Browse All Tags